TABITHA BRUINSMA: Open Payments
NPI 1629578083 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 19 payments from 16 companies in 2025. Trend: 2023 $14 · 2024 $512 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $132 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Cala Health, Inc. | 1 | $39 |
| Lundbeck LLC | 1 | $34 |
| CSL Behring | 1 | $28 |
| Cycle Pharmaceuticals Inc | 2 | $28 |
| Boston Scientific Corporation | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| GENZYME CORPORATION | 1 | $24 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $23 |
Products named: Leqembi, REXULTI, Cala kIQ, VYEPTI, Hizentra, Tascenso ODT, WaveWriter Alpha Prime 16, XIFAXAN.
Industry payments across FL — which companies pay providers there.
